HomeCompareUSX vs JNJ

USX vs JNJ: Dividend Comparison 2026

USX yields 32.52% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 USX wins by $122.5K in total portfolio value
10 years
USX
USX
● Live price
32.52%
Share price
$6.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$152.9K
Annual income
$21,694.05
Full USX calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — USX vs JNJ

📍 USX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUSXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, USX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
USX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

USX
Annual income on $10K today (after 15% tax)
$2,764.23/yr
After 10yr DRIP, annual income (after tax)
$18,439.94/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, USX beats the other by $14,402.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of USX + JNJ for your $10,000?

USX: 50%JNJ: 50%
100% JNJ50/50100% USX
Portfolio after 10yr
$91.7K
Annual income
$13,221.96/yr
Blended yield
14.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

USX
Analyst Ratings
3
Buy
6
Hold
1
Sell
Consensus: Hold
Altman Z
1.5
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

USX buys
0
JNJ buys
0
No recent congressional trades found for USX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUSXJNJ
Forward yield32.52%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$152.9K$30.5K
Annual income after 10y$21,694.05$4,749.88
Total dividends collected$107.5K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: USX vs JNJ ($10,000, DRIP)

YearUSX PortfolioUSX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,952$3,252.03$10,594$274.49+$3.4KUSX
2$19,169$4,240.42$11,294$360.69+$7.9KUSX
3$25,956$5,444.89$12,133$476.91+$13.8KUSX
4$34,663$6,890.30$13,156$635.42+$21.5KUSX
5$45,689$8,599.76$14,432$854.61+$31.3KUSX
6$59,481$10,593.74$16,056$1,162.76+$43.4KUSX
7$76,534$12,889.37$18,175$1,604.53+$58.4KUSX
8$97,391$15,499.73$21,009$2,252.68+$76.4KUSX
9$122,642$18,433.39$24,911$3,229.73+$97.7KUSX
10$152,921$21,694.05$30,458$4,749.88+$122.5KUSX

USX vs JNJ: Complete Analysis 2026

USXStock

U.S. Xpress Enterprises, Inc. operates as an asset-based truckload carrier providing services primarily in the United States. It operates through two segments, Truckload and Brokerage. The Truckload segment offers over-the-road trucking and contract services. The Brokerage segment provides non-asset-based freight brokerage services. The company offers customers a portfolio of services using its asset-based truckload fleet and third-party carriers through its non-asset-based truck brokerage network. As of December 31, 2021, its fleet consisted of approximately 6,400 tractors and 13,600 trailers, including 1,200 tractors provided by independent contractors. The company was founded in 1985 and is headquartered in Chattanooga, Tennessee.

Full USX Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this USX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

USX vs SCHDUSX vs JEPIUSX vs OUSX vs KOUSX vs MAINUSX vs ABBVUSX vs MRKUSX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.